Parkway Life REIT Streamlines Structure with Subsidiary Dissolution
Parkway Life Real Estate Investment Trust has dissolved four wholly-owned subsidiaries in France as part of an internal restructuring to streamline its group holding structure. This move is not expected to materially impact net tangible assets or distributions per unit for the financial year ending 31 December 2025. The latest analyst rating for Parkway Life REIT (SG:C2PU) is a Buy, with a price target of S$4.97. The trust focuses on healthcare-related real estate assets, aiming to provide stable returns to investors.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Parkway Life Real Estate Investment ( (SG:C2PU) ) has shared an update.
Parkway Life Real Estate Investment Trust has dissolved four of its wholly-owned subsidiaries in France as part of an internal restructuring to streamline its group holding structure. This dissolution is not expected to materially impact the net tangible assets or distributions per unit for the financial year ending 31 December 2025.
The most recent analyst rating on (SG:C2PU) stock is a Buy with a S$4.97 price target. To see the full list of analyst forecasts on Parkway Life Real Estate Investment stock, see the SG:C2PU Stock Forecast page.
More about Parkway Life Real Estate Investment
Parkway Life Real Estate Investment Trust, managed by Parkway Trust Management Limited, operates in the real estate investment industry. It focuses on healthcare and healthcare-related real estate assets, providing investors with stable returns through its portfolio of properties across Asia.
Average Trading Volume: 985,060
Technical Sentiment Signal: Buy
Current Market Cap: S$2.64B
